Wedbush Starts Cyteir Therapeutics (CYT) at Outperform
Tweet
Share
E-mailGet Alerts CYT Hot Sheet
Price: $3.02 --0%
Rating Summary:
5 Buy, 6 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 22 | New: 8
Rating Summary:
5 Buy, 6 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 22 | New: 8
Join SI Premium – FREE
Wedbush analyst Robert Driscoll initiates coverage on Cyteir Therapeutics (NASDAQ: CYT) with a Outperform rating and a price target of $40.00.
For an analyst ratings summary and ratings history on Cyteir Therapeutics click here. For more ratings news on Cyteir Therapeutics click here.
Shares of Cyteir Therapeutics closed at $19.65 yesterday.
You May Also Be Interested In
- UBS Starts Elevra Lithium (ELV:AU) at Buy
- JPMorgan Starts Banco de Sabadell SA (SAB:SM) (BNDSF) at Underweight
- Bernstein SocGen Group Starts WuXi AppTec Co Ltd (603259:CH) at Outperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
